Climatic seasonality, resource bottlenecks, and abundance of rainforest birds: implications for global climate change

We demonstrate that within-year climatic variability, particularly rainfall seasonality, is the most significant variable explaining spatial patterns of bird abundance in Australian tropical rainforest. The likely mechanism causing this pattern is a resource bottleneck (insects, nectar, and fruit) during the dry season that limits the population size of many species. The patterns support both the diversity–climatic–stability hypothesis and the species–energy hypothesis but clearly show that seasonality in energy availability may be a more significant factor than annual totals or means. An index of dry season severity is proposed that quantifies the combined effect of the degree of dryness and the duration of the dry season. We suggest that the predicted increases in seasonality due to global climate change could produce significant declines in bird abundance, further exacerbating the impacts of decreased range size, increased fragmentation, and decreased population size likely to occur as a result of increasing temperature. We suggest that increasing climatic seasonality due to global climate change has the potential to have significant negative impacts on tropical biodiversity.     

Festschrift: Short Shrift?

Book reviewed in this article:
From Tzintzuntan to the "Image of Limited Good": Essays in Honor of George M. Foster. M. Clark, R. Kemper , and C. Nelson .
Essays in Humanistic Anthropology: A Festschrift in Honor of David Bidney. Bruce T. Grindal and Dennis M. Warren .
Cross-Examinations. P. H. Gulliver .
Currents in Anthropology: Essays in Honor of Sol Tax. Robert Hinshaw .     

Comparison of aggregation enhancement and inhibition as strategies for reducing the cytotoxicity of the aortic amyloid polypeptide medin

Aortic medial amyloid (AMA) occurs as localised non-atheromatous plaques in virtually all individuals over the age of 50. The major protein component of AMA is the 50-residue polypeptide medin. Here we propose two methods of manipulating medin aggregation to reduce the cytotoxic species of medin: either by promoting formation of larger benign species or retaining small non-cytotoxic species. Medin co-localises with a variety of factors including glycosaminoglycans (GAGs). The first approach shows that the GAG heparin enhances the rate of medin aggregation and alters the morphology of the amyloid fibrils. Cellular viability measurements suggest that heparin eliminates small cytotoxic species of medin, promoting formation of benign fibrils. The second approach applies a previously successful approach of designing small peptide moieties that are complementary to the key amyloidogenic sequence but which contain modified amino acids known to disrupt hydrogen bonding and therefore prevent aggregation of the target protein. This approach also reduces cellular toxicity of medin at all stages of the aggregation process examined exhibiting a different mode of action to heparin. These results raise the question of whether enhancement of medin aggregation by GAGs is beneficial, by eliminating toxic oligomers, or has deleterious effects by reducing arterial plasticity associated with increased fibril load and whether small peptide inhibitors can be applied as drug candidates for amyloid diseases.     

Routine prenatal screening for HIV in a low-prevalence setting

BACKGROUND: The objectives of this study were to assess the effect of British Columbia''s June 1994 guidelines for prenatal HIV screening on the rate of maternal-fetal HIV transmission and to estimate the cost-effectiveness of such screening. METHODS: The authors conducted a retrospective review of pregnancy and delivery statistics, HIV screening practices, laboratory testing volume, prenatal and labour management decisions of HIV-positive women, maternal-fetal transmission rates and associated costs. RESULTS: Over 1995 and 1996, 135,681 women were pregnant and 92,645 carried to term. The rate of HIV testing increased from 55% to 76% of pregnancies on chart review at one hospital between November 1995 and November 1996. On the basis of seroprevalence studies, an estimated 50.2 pregnancies and 34.3 (95% confidence interval 17.6 to 51.0) live births to HIV-positive women were expected. Of 42 identified mother-infant pairs with an estimated date of delivery during 1995 or 1996, 25 were known only through screening. Of these 25 cases, there were 10 terminations, 1 spontaneous abortion and 14 cases in which the woman elected to carry the pregnancy to term with antiretroviral therapy. There was one stillbirth. One instance of maternal-fetal HIV transmission occurred among the 13 live births. The net savings attributable to prevented infections among babies carried to term were $165,586, with a saving per prevented case of $75,266. INTERPRETATION: A routine offer of pregnancy screening for HIV in a low-prevalence setting reduces the rate of maternal-fetal HIV transmission and may rival other widely accepted health care expenditures in terms of cost-effectiveness.